FDA
approval
· 2025-12-22
FDA Approved: BUTRANS — Supplemental Application (Purdue Pharma LP)
Summary
FDA approved a supplemental application for BUTRANS (buprenorphine) from Purdue Pharma LP.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUTRANS (BUPRENORPHINE)